Author:
Lupi Saturnino Marco,Farahani Mohammad Reza Dermenaki,Ronza Elisa Di,Cerri Michael,Baena Arianna Rodriguez y,Baena Ruggero Rodriguez y
Abstract
Recently, four new oral anticoagulant – dabigatran etexilate (direct thrombin inhibitor) and rivaroxaban, apixaban and edoxaban (Xa factor direct inhibitor) – have been approved for the prevention of venous thrombosis and cardiovascular events. As the number of patients taking these drugs is increasing, it is important that the dentist is familiar with these new oral anticoagulants, their indications, methods of action and in particular the management of the patients undergoing oral surgery.
This literature review is conducted to highlight the medical uses of these new oral anticoagulants and their pharmacologic properties, the clinical condition of the patient that may influence the choice to discontinue the DOAC and peri-operative management of the patient. Collaboration with the attending physician is crucial.
Reference27 articles.
1. Poulakos M, Walker JN, Baig U, David T. Edoxaban: A direct oral anticoagulant. Am J Heal Pharm 2017. https://doi.org/10.2146/ajhp150821
2. Miranda M, Martinez LS, Franco R, Forte V, Barlattani AJ, Bollero P. Differences between warfarin and new oral anticoagulants in dental clinical practice. Oral Implantol (Rome) 2016; 9: 151-6. https://doi:10.11138/orl/2016.9.3.151
3. Wienen W, Stassen J-M, Priepke H, Ries UJ, Hauel N. Invitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate. Thromb Haemost 2007. https://doi.org/10.1160/TH07-03-0183
4. Hauel NH, Nar H, Priepke H, Ries U, Stassen JM, Wienen W. Structure-based design of novel potent nonpeptide thrombin inhibitors. J Med Chem 2002. https://doi.org/10.1021/jm0109513
5. Stangier J, Rathgen K, Stähle H, Gansser D, Roth W. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 2007. https://doi.org/10.1111/j.1365-2125.2007.02899.x